carnitine has been researched along with 4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banner, DW; Benz, J; Chomienne, O; De Roo, E; Gsell, B; Hennig, M; Mueller, F; Rufer, AC; Stihle, M; Thoma, R | 1 |
| Benz, J; Chomienne, O; Hennig, M; Lomize, A; Rufer, AC; Thoma, R | 1 |
| Arduini, A; Carminati, P; Conti, R; Giannessi, F; Mannucci, E; Pessotto, P; Tassoni, E | 1 |
| Calienni, M; Calvani, M; D'Apolito, M; Koverech, A; Margarucci, S; Montanaro, L; Nicolai, R; Pacilli, A; Pasquinelli, G; Peluso, G; Petillo, O; Rocchi, L | 1 |
| Allegretti, M; Calarco, A; Foà, R; Licchetta, R; Mirabilii, S; Nicolai, R; Peluso, G; Ricciardi, MR; Tafuri, A; Torrisi, MR | 1 |
| Deng, F; Liu, X; Qu, Q; Wang, QJ; Zeng, F | 1 |
1 review(s) available for carnitine and 4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate
| Article | Year |
|---|---|
Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Carnitine; Carnitine O-Palmitoyltransferase; Cytoplasm; Fatty Acids; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Lipid Metabolism; Mitochondria; Molecular Targeted Therapy; NADP; Neoplasms; Oxidation-Reduction | 2016 |
5 other study(ies) available for carnitine and 4-trimethylammonio-3-((tetradecylcarbamoyl)amino)butyrate
| Article | Year |
|---|---|
The crystal structure of carnitine palmitoyltransferase 2 and implications for diabetes treatment.
Topics: Amino Acid Sequence; Animals; Betaine; Binding Sites; Carnitine; Carnitine O-Palmitoyltransferase; Crystallography, X-Ray; Diabetes Mellitus; Humans; Lipid Metabolism; Models, Chemical; Models, Molecular; Molecular Sequence Data; Mutation; Phenotype; Protein Binding; Protein Conformation; Protein Structure, Quaternary; Protein Structure, Secondary; Protein Structure, Tertiary; Proteins; Rats; Substrate Specificity; Ultracentrifugation | 2006 |
Carnitine palmitoyltransferase 2: analysis of membrane association and complex structure with a substrate analog.
Topics: Animals; Binding Sites; Carnitine; Carnitine O-Palmitoyltransferase; Crystallography, X-Ray; Mitochondrial Membranes; Models, Molecular; Models, Theoretical; Protein Binding; Protein Denaturation; Rats; Substrate Specificity | 2007 |
Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis.
Topics: Analysis of Variance; Animals; Area Under Curve; Carnitine; Carnitine O-Palmitoyltransferase; Diabetes Mellitus, Type 2; Dietary Fats; Gluconeogenesis; Glucose; Heart; Hepatocytes; Homeostasis; Insulin Resistance; Liver; Male; Mice; Myocardium; PPAR alpha; Rats; Rats, Sprague-Dawley | 2011 |
Carnitine-acyltransferase system inhibition, cancer cell death, and prevention of myc-induced lymphomagenesis.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; B-Lymphocytes; Blotting, Western; Burkitt Lymphoma; Carnitine; Carnitine Acyltransferases; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Fatty Acids; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Lipid Metabolism; Mice; Oxidation-Reduction; Proto-Oncogene Proteins c-myc; Real-Time Polymerase Chain Reaction; Treatment Outcome; Up-Regulation | 2013 |
Targeting the leukemia cell metabolism by the CPT1a inhibition: functional preclinical effects in leukemias.
Topics: Carnitine; Carnitine O-Palmitoyltransferase; Cell Line, Tumor; Drug Delivery Systems; Fatty Acids; Humans; Leukemia, Myeloid, Acute; Neoplasm Proteins; Oxidation-Reduction | 2015 |